Alyeska Investment Group
ITOS

Alyeska Investment Group’s iTeos Therapeutics ITOS Stock Holding History

Alyeska Investment Group’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-500,000
Closed -$4.99M – 654
2025
Q2 		$4.99M Buy
+500,000
New +$4.03M 0.02% 425

Other funds holding ITOS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Alyeska Investment Group's ITOS Position: Q3 2025 in Review

Alyeska Investment Group sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 500,000 shares — an estimated $4.99M sold.

Alyeska Investment Group first reported a position in ITOS in Q2 2025 and held it in 1 quarter. The position peaked at $4.99M in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

  • Alyeska Investment Group reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Alyeska Investment Group sold 500,000 iTeos Therapeutics shares in Q3 2025, an estimated $4.99M.
  • Alyeska Investment Group first reported a position in iTeos Therapeutics in Q2 2025 and held it in 1 quarter.
  • Alyeska Investment Group's iTeos Therapeutics position peaked at $4.99M in Q2 2025.
  • 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Alyeska Investment Group's 13F filing for Q3 2025, filed 17 Nov 2025.